[1] 杨琼,江志敏,郭双双,等.吉西他滨固定剂量率输注一线治疗晚
期胰腺癌随机对照试验的Meta分析[J].中华肿瘤防治杂志,
2008,15(1):57.
[2] Therasse P, Arbuck SG, Eiscilhauer EA,et al.New guideline
to evaluate the response to treatment in solid turmor[J]. Natl
CancerInst,2000,92(3):205-216.
[3] 高志强,韩宝惠,沈洁,等.晚期非小细胞肺癌RRM1蛋白表达
与吉西他滨联合顺铂化疗疗效的关系[J]. 中国肺癌杂志,
2011,14(4):340-344.
[4] 彭传敏.37例肺癌恶性胸腔积液胸腔化疗联合吉西他滨、顺铂
全身化疗治疗观察[J].中外健康文摘,2011,8(21):242-243.
[5] 杜均祥,梁翠微,彭东旭,等.吉西他滨+顺铂方案化疗联合胸腔
灌注羟喜树碱治疗肺腺癌伴胸腔积液的临床研究[J].中国医
师进修杂志,2011,34(19):37-38.
[6] Lee JJ, Maeng CH, Baek SK,et al.The immunohis to chemi?
cal over expression of ribonucleotide reductase regulatory sub?
unit M1(RRM1)protein is a predictor of shorter survival to
gemcitabine-based chemotherapy in advanced non-small cell
lung cancer (NSCLC)[J]. Lung Cancer,2010,70(2):205.
[7] 袁野.吉西他滨联合顺铂治疗72例晚期非小细胞肺癌疗效观察
[J].中国医药指南,2010,8(35):93.